Psoriatic Arthritis Excellence Forum Excellence Forum

Psoriatic Arthritis

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

Quiz

06/16/2023

Priyam Vora, Associate Editor

The Psoriasis Epidemiology Screening Tool (PEST) can help identify patients with psoriasis at higher risk of developing psoriatic arthritis. Do you know the key indicator? Take our quiz to find out!

The Psoriasis Epidemiology...

06/16/2023

Rheumatology & Arthritis

Quiz

Treatment Burdens of Methotrexate and TNFis in PsA

05/10/2023

Priyam Vora, Associate Editor

Both methotrexate and biologics have some burden associated with treatment, from side effects to dealing with insurance coverage. But which burdens are greatest for patients with psoriatic arthritis? Find out what Dr Alexis Ogdie discovered...

Both methotrexate and biologics...

05/10/2023

Rheumatology & Arthritis

Conference Coverage

Megan Meier, MD, on Direct-to-Patient Screening of PsA

04/11/2023

Priyam Vora, Associate Editor

Data from the Psoriasis Epidemiology Screening Tool survey found that evaluation by a rheumatologist was beneficial in patient-driven psoriatic arthritis screening.

Data from the Psoriasis...

04/11/2023

Rheumatology & Arthritis

Quiz

PsA and PEST

04/05/2023

Priyam Vora, Associate Editor

Alexis Ogdie, MD, surveyed patients with psoriasis with the Psoriasis Epidemiology Screening Tool (PEST), a 5-item questionnaire on body parts affected by psoriasis and musculoskeletal symptoms among patients. What percentage of these...

Alexis Ogdie, MD, surveyed...

04/05/2023

Rheumatology & Arthritis

Conference Coverage

Alexis Ogdie, MD, on Clinical Measures and PROs in PsA

03/17/2023

Dr Ogdie, from the University of Pennsylvania, discusses the analysis of results from the KEEPsAKE trials of risankizumab regarding the association of clinical measures and patient-reported outcomes in psoriatic arthritis.

Dr Ogdie, from the University of...

03/17/2023

Rheumatology & Arthritis

Conference Coverage

Saakshi Khattri, MD, MBBS, on the Impact of Risankizumab on Enthesitis and Dactylitis in PsA

03/07/2023

Rebecca Mashaw, Managing Editor

Rebecca Mashaw, Managing Editor ...

Results from the KEEPsAKE 1 and 2 trials demonstrated the efficacy of risankizumab in achieving and maintaining resolution of dactylitis and enthesitis among patients with psoriatic arthritis.

Results from the KEEPsAKE 1 and...

03/07/2023

Rheumatology & Arthritis

Conference Coverage

Alexis Ogdie, MD, on PEST Screening Among Patients With PsO

02/13/2023

Rebecca Mashaw, Managing Editor

Rebecca Mashaw, Managing Editor ...

Dr Ogdie, from the University of Pennsylvania, presented an abstract at ACR Convergence 2022 on research she and colleagues conducted highlighting the need to actively screen patients with psoriasis for their risk of developing psoriatic...

Dr Ogdie, from the University of...

02/13/2023

Rheumatology & Arthritis

Conference Coverage

Lihi Eder, MD, PhD, on Assessing the Effectiveness of COVID-19 Vaccines Among Patients With Psoriatic Disease

12/19/2022

Dr Eder and colleagues used data from Israeli health services to compare immune responses among patients with psoriatic arthritis and/or psoriasis and general population controls to COVID-19 vaccines.

Dr Eder and colleagues used data...

12/19/2022

Rheumatology & Arthritis

Conference Coverage

Alexis Ogdie, MD, on Response Rates in PsA: Results from the KEEPsAKE Trials of Risankizumab

11/14/2022

Dr Ogdie, from the University of Pennsylvania, reviews her poster presentation from ACR Convergence 2022 on response rates among patients treated with risankizumab based on the number of swollen and tender joints, from the KEEPsAKE 1 and 2...

Dr Ogdie, from the University of...

11/14/2022

Rheumatology & Arthritis

Conference Coverage

Kelly Gavigan, MPH, on Online Wellness Programs for Patients with PsA

11/12/2022

Through a cross-sectional online survey, Dr Gavighan and colleagues sought to examine the views and attitudes of individuals with psoriatic arthritis about using a guided online wellness program to manage their disease.

Through a cross-sectional online...

11/12/2022

Rheumatology & Arthritis

Stay in the Know

Rheumatology & Arthritis Newsletter

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1

Popular Articles

Sponsored Video

The RheuMuseum Lecture Series: A Deeper Understanding of the Pathogenesis of axSpA

07/03/2024

Professor Iain McInnes of the University of Glasgow delves into the latest science on the importance of the interleukin-12 interleukin-17 axis in axial spondyloarthritis.

Professor Iain McInnes of the...

07/03/2024

Rheumatology & Arthritis

News

Patients With nr-axSpA and r-axSpA Show Differences in Several Key Criteria

06/24/2024

Researchers found distinct variations between patients with nonradiographic and radiographic axial spondyloarthritis in age of disease onset, sex, and other factors.

Researchers found distinct...

06/24/2024

Rheumatology & Arthritis

News

Monitoring axSpA Disease Activity in Clinical Practice

06/14/2024

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...

A composite measure of disease activity in axial spondyloarthritis that includes extra-articular manifestations could provide more accurate assessments, researchers say.

A composite measure of disease...

06/14/2024

Rheumatology & Arthritis

Podcast

Nonrad AxSpA and the Disease Burden on the Patient

10/05/2023

Featuring Dr Mohamad Bittar

Dr Bittar educates the listeners on the core differences and similarities between ankylosing spondylitis and axial spondyloarthritis; and provides guidance on diagnosing and monitoring/ treating patients with various forms of axial diseases.

Dr Bittar educates the listeners...

10/05/2023

Autoimmune

Psoriatic Arthritis Excellence Forum Excellence Forum

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products